Xeraya Capital is a private equity and venture capital firm.
Business Model:
Revenue: $3.1M
Employees: 11-50
Address: 199 Jalan Tun Razak
City: Kuala Lumpur
State: selangor
Zip: 50400
Country: MY
Xeraya Capital is a private equity and venture capital firm that focuses on investments in life science companies.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
6/2019 | Acutus Medical | Series D | 0 |
7/2015 | ViewRay | Post-IPO Equity | 0 |
3/2014 | invendo medical | Venture Round | 0 |
11/2020 | Congenica | Series C | 50M |
9/2016 | Chrono Therapeutics | Series B | 47.6M |
5/2020 | Greenlight Biosciences | Venture Round | 0 |
12/2021 | Viron | Series B | 50M |
6/2019 | Viron | Series A | 25M |
8/2016 | Iconic Therapeutics | Series C | 10M |
2/2020 | Aria CV | Series B | 0 |
11/2020 | InterVenn | Series B | 0 |
3/2017 | P2 Science | Series B | 0 |
12/2021 | OncoMyx Therapeutics | Series B | 0 |
3/2016 | Acutus Medical | Series C | 75M |
2/2018 | Liquidia Technologies | Series D | 25.5M |
10/2014 | PrIME Biologics | Venture Round | 12.6M |
5/2020 | Rapid Micro Biosystems | Private Equity Round | 0 |
1/2020 | P2 Science | Series C | 0 |
2/2022 | Greenlight Biosciences | Post-IPO Equity | 0 |
10/2015 | Boston Neurosciences Inc | Series A | 0 |
8/2016 | ViewRay | Post-IPO Equity | 0 |
5/2018 | Rapid Micro Biosystems | Private Equity Round | 60M |
5/2010 | Gevo | Series D | 0 |
11/2020 | Imago BioSciences | Series C | 80M |
2/2022 | Greenlight Biosciences | Post-IPO Equity | 0 |
12/2021 | OncoMyx Therapeutics | Series B | 0 |
12/2021 | Viron Inc. | Series B | 0 |
11/2020 | Imago BioSciences | Series C | 0 |
11/2020 | InterVenn | Series B | 0 |
11/2020 | Congenica | Series C | 0 |
5/2020 | Rapid Micro Biosystems | Private Equity Round | 0 |
5/2020 | Greenlight Biosciences | Venture Round | 0 |
2/2020 | Aria CV | Series B | 0 |
1/2020 | P2 Science | Series C | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|